Filed: 10/24/2024ACC: 0000950123-24-009887
📋 What this filing means
NOVO HOLDINGS A/S filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $2.01B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$2.01B
Total AUM (reported)
66.62M
Total Shares
Allocation by class
COM$1.02B50.7%
TOTAL STK MKT$294.08M14.6%
CL A$230.61M11.5%
CL A LTD VT SH$185.56M9.2%
N Y REGISTRY SHS$111.10M5.5%
SPONSORED ADS$53.15M2.6%
COM PAR $.01$52.90M2.6%
Portfolio Concentration
Top 3$710.25M35.3%
4–10$670.17M33.3%
11–25$535.99M26.6%
Rest$97.04M4.8%
Top 3 weight
35.3%
Top 10 weight
68.6%
Voting Authority Distribution
Total shares with voting rights: 66.62M
Sole
Full voting authority
66.62M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
VANGUARD INDEX FDS
SOLEShares1.04M
TypeSH
Market value$294.08M
14.61%
Sole
1.04M
Shared
0.00
None
0.00
TEMPUS AI INC
SOLEShares4.07M
TypeSH
Market value$230.61M
11.45%
Sole
4.07M
Shared
0.00
None
0.00
BROOKFIELD CORP
SOLEShares3.49M
TypeSH
Market value$185.56M
9.22%
Sole
3.49M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares5.55M
TypeSH
Market value$148.13M
7.36%
Sole
5.55M
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares2.41M
TypeSH
Market value$111.60M
5.54%
Sole
2.41M
Shared
0.00
None
0.00
ASML HOLDING N V
SOLEShares133.34K
TypeSH
Market value$111.10M
5.52%
Sole
133.34K
Shared
0.00
None
0.00
SALESFORCE INC
SOLEShares368.56K
TypeSH
Market value$100.88M
5.01%
Sole
368.56K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares750K
TypeSH
Market value$85.70M
4.26%
Sole
750K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares1.50M
TypeSH
Market value$58.50M
2.91%
Sole
1.50M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares2.38M
TypeSH
Market value$54.26M
2.69%
Sole
2.38M
Shared
0.00
None
0.00
ALIBABA GROUP HLDG LTD
SOLEShares500.83K
TypeSH
Market value$53.15M
2.64%
Sole
500.83K
Shared
0.00
None
0.00
INSMED INC
SOLEShares724.67K
TypeSH
Market value$52.90M
2.63%
Sole
724.67K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares1M
TypeSH
Market value$51.10M
2.54%
Sole
1M
Shared
0.00
None
0.00
CABLE ONE INC
SOLEShares118.40K
TypeSH
Market value$41.42M
2.06%
Sole
118.40K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares1.51M
TypeSH
Market value$35.37M
1.76%
Sole
1.51M
Shared
0.00
None
0.00
MERUS N V
SOLEShares700K
TypeSH
Market value$34.97M
1.74%
Sole
700K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares490K
TypeSH
Market value$34.44M
1.71%
Sole
490K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares963.66K
TypeSH
Market value$32.75M
1.63%
Sole
963.66K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares118.38K
TypeSH
Market value$32.56M
1.62%
Sole
118.38K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.73M
TypeSH
Market value$31.95M
1.59%
Sole
1.73M
Shared
0.00
None
0.00
LANZATECH GLOBAL INC
SOLEShares15.81M
TypeSH
Market value$30.21M
1.50%
Sole
15.81M
Shared
0.00
None
0.00
BROOKFIELD ASSET MANAGMT LTD
SOLEShares627.21K
TypeSH
Market value$29.66M
1.47%
Sole
627.21K
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares1.54M
TypeSH
Market value$28.49M
1.41%
Sole
1.54M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares2.50M
TypeSH
Market value$26.70M
1.33%
Sole
2.50M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$20.32M
1.01%
Sole
1.10M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VANGUARD INDEX FDSSOLE | TOTAL STK MKT | 1.04M | SH | $294.08M 14.61% | 1.04M | 0.00 | 0.00 |
TEMPUS AI INCSOLE | CL A | 4.07M | SH | $230.61M 11.45% | 4.07M | 0.00 | 0.00 |
BROOKFIELD CORPSOLE | CL A LTD VT SH | 3.49M | SH | $185.56M 9.22% | 3.49M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 5.55M | SH | $148.13M 7.36% | 5.55M | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 2.41M | SH | $111.60M 5.54% | 2.41M | 0.00 | 0.00 |
ASML HOLDING N VSOLE | N Y REGISTRY SHS | 133.34K | SH | $111.10M 5.52% | 133.34K | 0.00 | 0.00 |
SALESFORCE INCSOLE | COM | 368.56K | SH | $100.88M 5.01% | 368.56K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 750K | SH | $85.70M 4.26% | 750K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 1.50M | SH | $58.50M 2.91% | 1.50M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.38M | SH | $54.26M 2.69% | 2.38M | 0.00 | 0.00 |
ALIBABA GROUP HLDG LTDSOLE | SPONSORED ADS | 500.83K | SH | $53.15M 2.64% | 500.83K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 724.67K | SH | $52.90M 2.63% | 724.67K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 1M | SH | $51.10M 2.54% | 1M | 0.00 | 0.00 |
CABLE ONE INCSOLE | COM | 118.40K | SH | $41.42M 2.06% | 118.40K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 1.51M | SH | $35.37M 1.76% | 1.51M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 700K | SH | $34.97M 1.74% | 700K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 490K | SH | $34.44M 1.71% | 490K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 963.66K | SH | $32.75M 1.63% | 963.66K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 118.38K | SH | $32.56M 1.62% | 118.38K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.73M | SH | $31.95M 1.59% | 1.73M | 0.00 | 0.00 |
LANZATECH GLOBAL INCSOLE | COM | 15.81M | SH | $30.21M 1.50% | 15.81M | 0.00 | 0.00 |
BROOKFIELD ASSET MANAGMT LTDSOLE | CL A LMT VTG SHS | 627.21K | SH | $29.66M 1.47% | 627.21K | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 1.54M | SH | $28.49M 1.41% | 1.54M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 2.50M | SH | $26.70M 1.33% | 2.50M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $20.32M 1.01% | 1.10M | 0.00 | 0.00 |
Page 1 of 2